United Therapeutics (UTHR) Convertible Debt (2011 - 2013)
United Therapeutics (UTHR) posted Convertible Debt of $207.4 million for Q1 2013, up 1.33% sequentially from $204.7 million in Q4 2012, and up 5.41% YoY from $196.7 million in Q1 2012.
United Therapeutics (UTHR) Convertible Debt (2011 - 2013) Analysis & Trends
United Therapeutics has reported Convertible Debt for 3 years, with the latest figure at $207.4 million in Q1 2013.
- Quarterly Convertible Debt rose 5.41% year-over-year to $207.4 million in Q1 2013, while the trailing twelve-month figure through Mar 2013 was $207.4 million (up 5.41% YoY) and the FY2012 annual result came in at $204.7 million, up 5.4% from the prior year.
- Convertible Debt advanced to $207.4 million in Q1 2013 per UTHR's latest filing, from $204.7 million in the prior quarter.
- Over five years, Convertible Debt peaked at $207.4 million in Q1 2013 and troughed at $194.2 million in Q4 2011.
- A 3-year average of $200.7 million and a median of $200.7 million in 2012 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2012 and 2013: Convertible Debt increased 5.4% in 2012, then increased 5.41% in 2013.
- Over 3 years, Convertible Debt stood at $194.2 million in 2011, then increased by 5.4% to $204.7 million in 2012, then grew by 1.33% to $207.4 million in 2013.
- According to Business Quant data, Convertible Debt over the past three periods registered $207.4 million, $204.7 million, and $202.0 million for Q1 2013, Q4 2012, and Q3 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 207.38 Mn |
| Dec 31, 2012 | 204.67 Mn |
| Sep 30, 2012 | 201.97 Mn |
| Jun 30, 2012 | 199.34 Mn |
| Mar 31, 2012 | 196.73 Mn |
| Dec 31, 2011 | 194.18 Mn |